Mangalam Drugs And Organics Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on August 12, 2025
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs and Organics Limited has informed exchanges that the NCLT Mumbai Bench, vide its order dated June 30, 2025, has directed a meeting of the company's equity shareholders on Tuesday, August 12, 2025, at 12:30 PM via video conferencing. The meeting will consider and approve the Scheme of Merger by Absorption of two private group companies — Mangalam Laboratories Private Limited (MLPL) and Shri JB Pharma Private Limited (SJPPL, formerly Shri JB Pharma LLP) — into the listed entity MDOL, under Sections 230-232 of the Companies Act, 2013. The application was filed as C.A. (CAA)/67/MB/C-III/2025. Both BSE and NSE had earlier given no-objection observations (January 2025) for filing the scheme with NCLT. Remote e-voting will run from August 8 to August 11, 2025, with the cut-off date for voting eligibility fixed as August 5, 2025.
Shareholders of MDOL should review the scheme details (share entitlement ratio, fairness opinion, audited financials of all three companies attached as annexures) and vote in the meeting. Approval by three-fourths in value of shares voting is required for the merger to proceed, after which it will go back to NCLT for final sanction — if cleared, MDOL will absorb both private companies into its consolidated structure.